Response to prothrombin complex concentrate to correct acquired abnormalities of the clotting screen in patients with liver impairment
Liver Int
.
2017 Aug;37(8):1250-1251.
doi: 10.1111/liv.13412.
Authors
Michael J R Desborough
1
2
,
Simon J Stanworth
1
2
,
Vipul Jairath
3
4
Affiliations
1
NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.
2
Oxford Clinical Research in Transfusion Medicine, Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, UK.
3
Department of Medicine, Division of Gastroenterology, Western University & London Health Sciences Centre, London, ON, Canada.
4
Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.
PMID:
28710820
DOI:
10.1111/liv.13412
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Coagulation Factors*
Blood Coagulation Tests*
Humans
Liver Diseases
Prothrombin
Substances
Blood Coagulation Factors
prothrombin complex concentrates
Prothrombin